Azelnidipine
![]() | |
| Clinical data | |
|---|---|
| Trade names | CalBlock |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
123524-52-7 |
| PubChem (CID) | 65948 |
| ChemSpider |
59352 |
| UNII |
PV23P19YUG |
| KEGG |
D01145 |
| ChEMBL |
CHEMBL1275868 |
| Chemical and physical data | |
| Formula | C33H34N4O6 |
| Molar mass | 582.64 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Azelnidipine (INN; marketed under the brand name CalBlock — カルブロック) is a dihydropyridine calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.[1]
References
- ↑ Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T (September 1989). "Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker". Jpn. J. Pharmacol. 51 (1): 57–64. doi:10.1254/jjp.51.57. PMID 2810942.Scholar search
This article is issued from Wikipedia - version of the 8/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
